CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

EZH2 activating mutation

Gene: EZH2 · Type: mutation

Indications: Follicular lymphoma, Epithelioid sarcoma

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
TazemetostatFollicular lymphoma, Epithelioid sarcomaINDICATED
FDA Label
Label